Dogma Therapeutics
Latest round
- Series A
Last raised
- Apr 2017
Total raised
- $3.5M
Investors
- 2
About Dogma Therapeutics
Based in Massachusetts, US, and established in 2017, Dogma Therapeutics is a biotechnology company that is developing oral small molecule drugs to treat high cholesterol and cardiovascular disease. The company founder is Doug Daniels. The company developed small molecule inhibitors of Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9), The function mutation of PCSK9 increased serum cholesterol and caused cardiovascular disease. Then, the company developed oral PCSK9 inhibitors for high cholesterol and cardiovascular disease. The oral PCSK9 inhibitors were developed, based on dozens of high-resolution x-ray structures of molecules bound, and structure-based design.
Who invested in Dogma Therapeutics
2 investors across 1 round
See all investors in Dogma Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 1, 2017
Amount
$3.5M
Investors
Questions about Dogma Therapeutics
Who invested in Dogma Therapeutics?
Dogma Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dogma Therapeutics raised?
Dogma Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Dogma Therapeutics last raise money?
Dogma Therapeutics's most recent round on record is a Series A, in Apr 2017.
What does Dogma Therapeutics do?
Based in Massachusetts, US, and established in 2017, Dogma Therapeutics is a biotechnology company that is developing oral small molecule drugs to treat high cholesterol and cardiovascular disease.
Where is Dogma Therapeutics headquartered?
Dogma Therapeutics is headquartered in US.
Which VCs invest in companies like Dogma Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Dogma Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Dogma Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.